These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3294977)

  • 1. A dose-response study of the bronchodilator action of azelastine in asthma.
    Kemp JP; Meltzer EO; Orgel HA; Welch MJ; Bucholtz GA; Middleton E; Spector SL; Newton JJ; Perhach JL
    J Allergy Clin Immunol; 1987 Jun; 79(6):893-9. PubMed ID: 3294977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the safety and efficacy of multiple doses of azelastine to adult patients with bronchial asthma over time.
    Tinkelman DG; Bucholtz GA; Kemp JP; Koepke JW; Repsher LH; Spector SL; Storms WW; Van As A
    Am Rev Respir Dis; 1990 Mar; 141(3):569-74. PubMed ID: 2178521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Duration of action of a single dose of azelastine in patients with chronic asthma.
    Chervinsky P; Grossman J; Freitag JJ
    J Asthma; 1995; 32(2):141-5. PubMed ID: 7559264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of upper and lower airway disease with azelastine.
    Perhach JL; Connell JT; Kemp JP
    N Engl Reg Allergy Proc; 1987; 8(2):121-4. PubMed ID: 2886905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of azelastine on bronchoconstriction induced by histamine and leukotriene C4 in patients with extrinsic asthma.
    Albazzaz MK; Patel KR
    Thorax; 1988 Apr; 43(4):306-11. PubMed ID: 2900560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of azelastine on exercise-induced asthma.
    Magnussen H; Reuss G; Jörres R; Aurich R
    Chest; 1988 May; 93(5):937-40. PubMed ID: 2896104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study of the clinical efficacy of azelastine in patients with extrinsic asthma, and its effect on airway responsiveness.
    Gould CA; Ollier S; Aurich R; Davies RJ
    Br J Clin Pharmacol; 1988 Nov; 26(5):515-25. PubMed ID: 2905153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corticosteroid-sparing effect of azelastine in the management of bronchial asthma.
    Busse WW; Middleton E; Storms W; Dockhorn RJ; Chu TJ; Grossman J; Weiler JM; Bronsky EA; Mansfield LE; Bell TD; Hemsworth GR; Perhach JL; D'Eletto TA; Dam A
    Am J Respir Crit Care Med; 1996 Jan; 153(1):122-7. PubMed ID: 8542104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacodynamic evaluation of azelastine in subjects with asthma.
    Spector SL; Perhach JL; Rohr AS; Rachelefsky GS; Katz RM; Siegel SC
    J Allergy Clin Immunol; 1987 Jul; 80(1):75-80. PubMed ID: 3298379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Azelastine in the prophylactic treatment of bronchial asthma: an Italian multicentre comparison with ketotifen.
    Ambrosi L; Bariffi F; Carino M; Catena E; Ceccarelli G; Ciampini M; Condoluci M; Crimi N; Ferretti G; Gambaro G
    J Int Med Res; 1989; 17(3):218-25. PubMed ID: 2569993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double-blind assessment of azelastine in the treatment of perennial allergic rhinitis.
    Grossman J; Halverson PC; Meltzer EO; Shoenwetter WF; van Bavel JH; Woehler TR; Freitag JJ; Hemsworth GR
    Ann Allergy; 1994 Aug; 73(2):141-6. PubMed ID: 8067597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of azelastine on the infiltration of inflammatory cells into the bronchial mucosa and clinical changes in patients with bronchial asthma.
    Hoshino M; Nakamura Y
    Int Arch Allergy Immunol; 1997 Nov; 114(3):285-92. PubMed ID: 9363911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicenter, double-blind, multiple-dose, parallel-groups efficacy and safety trial of azelastine, chlorpheniramine, and placebo in the treatment of spring allergic rhinitis.
    Weiler JM; Donnelly A; Campbell BH; Connell JT; Diamond L; Hamilton LH; Rosenthal RR; Hemsworth GR; Perhach JL
    J Allergy Clin Immunol; 1988 Nov; 82(5 Pt 1):801-11. PubMed ID: 3057041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of azelastine on allergen- and exercise-induced asthma.
    Motojima S; Ohashi Y; Otsuka T; Fukuda T; Makino S
    Asian Pac J Allergy Immunol; 1985 Dec; 3(2):174-8. PubMed ID: 3907651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The bronchodilator effects and pharmacokinetics of caffeine in asthma.
    Becker AB; Simons KJ; Gillespie CA; Simons FE
    N Engl J Med; 1984 Mar; 310(12):743-6. PubMed ID: 6700656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An evaluation of the efficacy and safety of azelastine in patients with chronic asthma. Azelastine-Asthma Study Group.
    J Allergy Clin Immunol; 1996 Jun; 97(6):1218-24. PubMed ID: 8648016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of the combination of inhaled ipratropium and oral theophylline in asthma.
    Burki NK
    Chest; 1997 Jun; 111(6):1509-13. PubMed ID: 9187165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The inhibitory actions of azelastine hydrochloride on the early and late bronchoconstrictor responses to inhaled allergen in atopic asthma.
    Rafferty P; Ng WH; Phillips G; Clough J; Church MK; Aurich R; Ollier S; Holgate ST
    J Allergy Clin Immunol; 1989 Nov; 84(5 Pt 1):649-57. PubMed ID: 2572616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic protective effects with azelastine and salbutamol in a guinea pig asthma model.
    Chand N; Achterrath-Tuckermann U; Szelenyi I; Sofia RD
    Res Commun Mol Pathol Pharmacol; 1995 Feb; 87(2):125-32. PubMed ID: 7749650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Azelastine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential.
    McTavish D; Sorkin EM
    Drugs; 1989 Nov; 38(5):778-800. PubMed ID: 2574665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.